IGTP will coordinate a European project to improve the diagnosis and treatment of neurofibromatoses

Researchers from the Clinical Genomics Group at Germans Trias i Pujol Research Institute (IGTP) and the Genetics Service at Germans Trias i Pujol Hospital (HUGTiP) will coordinate the project EURONET-NF, which aims to improve genetic diagnosis for patients with neurofibromatoses and schwannomatosis (NF-SWN). The project, which involves 6 countries, has been awarded around €1.6 million in funding by the European Union for the next 3 years.Researchers from the Clinical Genomics Group at Germans Trias i Pujol Research Institute (IGTP) and the Genetics Service at Germans Trias i Pujol Hospital (HUGTiP) will coordinate the project EURONET-NF, which aims to improve genetic diagnosis for patients with neurofibromatoses and schwannomatosis (NF-SWN). The project, which involves 6 countries, has been awarded around €1.6 million in funding by the European Union for the next 3 years.

A new study with the GCAT cohort analyses pigmentary traits and their relationship with diseases

Researchers from the GCAT|Genomes for Life project of the IGTP have analysed the genetic basis of 13 pigment traits and their association with diseases. The work has been published this month in Genes. 

The Legionellosis Study Group consolidates its position as a reference research group in Catalonia

The Public Health Agency of Catalonia (ASPCAT) has increased the budget granted to the Legionellosis Study Group (GELeg) of the Clinical and Environmental Infectious Diseases Research Group (CEID) of the Germans Trias i Pujol Research Institute (IGTP), ratifying its confidence in the resolution of Legionella outbreaks. The increase is almost double the budget items of previous years and will expand the scope of the work carried out in the laboratory.

Two studies from the Immunology group on autoimmunity and hematopoietic stem cells show promising therapeutic potential

The first study, published in Nanomedicine: Nanotechnology, Biology and Medicine, seeks a strategy to safely and definitevely restore self-tolerance in autoimmune diseases; the second, in Archivum Immunologiae et Therapiae Experimentalis, bets on making the most of umbilical cord blood cells, key against hematological diseases

Two IGTP projects, financed with 1.6 million euros by the European Commission

The European Commission has granted two projects to the IGTP within the HORIZON programme, which add up to a total of 1,670,346 euros in funding and deal with the preclinical development of immunotherapies.

In vitro development of a new personalized therapy for patients with neurofibromatosis type 2

Researchers from the Clinical Genomics group of the Germans Trias i Pujol Research Institute (IGTP) and the Genetics Service of the Germans Trias Hospital (HUGTiP) have developed a new in vitro therapy to recover part of the function encoded by the gene NF2, which, when altered, induces the development of neurofibromatosis type 2. The study has been published in the prestigious journal Molecular Therapy Nucleic Acids.

A study of more than 750 healthcare professionals confirms that antibodies persist 17 months after having suffered from COVID-19

• Research has also confirmed that people who suffered from the disease in a serious way generate more antibodies than those who had moderate and mild effects.
• The results of this study show significant differences in the generation of antibodies between men and women on day 30 of infection and for all antibodies measured.
• This is one of the largest studies carried out to date in Catalonia, both in terms of the volume of participants and the length of follow-up.

A project that develops a new immunotherapy based on a monoclonal antibody to treat cancer is one of the three initiatives chosen by CaixaResearch Consolidate

A project that develops a monoclonal antibody for cancer treatment, led by the Innate Immunity Research Group at the IGTP, is one of the three selected in the CaixaResearch Consolidate call of “la Caixa” Foundation to cutting-edge innovative biomedical projects.

Study Sets the Basis for Identifying Biomarkers of Latent Malaria Vivax Infections

Using a mouse model, the research team characterized the protein profile of small vesicles secreted by liver cells, where the latent form of the parasite hides.

A diet rich in plant-based omega-3 is associated with better outcomes in heart failure patients

Higher levels of plant-based omega-3 fats reduce the risk of death and hospital admission in people with heart failure. This is according to a joint study by researchers at Germans Trias i Pujol Hospital and Research Institute and the Hospital del Mar Medical Research Institute, published in the Journal of the American College of Cardiology, involving the follow-up of almost a thousand patients.